Myc pathway-guided alternative splicing events predict the overall survival of lung squamous cell carcinoma
Oncogenic signaling pathways-guided alternative splicing events and their clinical prognostic values were investigated in lung squamous cell carcinoma (LUSC). RNAseq and AS data of LUSC were obtained from TCGA and SpliceSeq database, respectively. Pathway enrichment-guided activity study of alternat...
Main Authors: | Youming Lei, Jian Xiao, Wei Zhao, Fanghao Liu, Yi Sui, Kun Wang, Yinqiang Liu |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2022-12-01
|
Series: | All Life |
Subjects: | |
Online Access: | http://dx.doi.org/10.1080/26895293.2022.2043449 |
Similar Items
-
Switched alternative splicing events as attractive features in lung squamous cell carcinoma
by: Boxue He, et al.
Published: (2022-01-01) -
Prognostic role of alternative splicing events in head and neck squamous cell carcinoma
by: Yanni Ding, et al.
Published: (2020-05-01) -
Comprehensive Analysis of Prognostic Alternative Splicing Signatures in Oral Squamous Cell Carcinoma
by: Ruoyan Cao, et al.
Published: (2020-08-01) -
Anti‐tumor efficacy of a novel CLK inhibitor via targeting RNA splicing and MYC‐dependent vulnerability
by: Kenichi Iwai, et al.
Published: (2018-06-01) -
TRIM25 promotes glioblastoma cell growth and invasion via regulation of the PRMT1/c-MYC pathway by targeting the splicing factor NONO
by: Yike Chen, et al.
Published: (2024-02-01)